Evidence map›Paper›PMID 35358301›Full record

ArticleJournal of Crohn's & colitis2022

IL10 Secretion Endows Intestinal Human iNKT Cells with Regulatory Functions Towards Pathogenic T Lymphocytes.

Claudia Burrello, Francesco Strati, Georgia Lattanzi, Angelica Diaz-Basabe, Erika Mileti, Maria Rita Giuffrè, Gianluca Lopez, Fulvia Milena Cribiù, Elena Trombetta, Marinos Kallikourdis and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of Crohn's & colitis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. VSL#3British journal of biomedical science · 2026
    Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Gut microbes
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Claudia BurrelloDepartment of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0003-2249-5588
Francesco StratiDepartment of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0001-7217-3355
Georgia LattanziDepartment of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.
Angelica Diaz-BasabeDepartment of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0003-2096-1223
Erika MiletiDepartment of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.
Maria Rita GiuffrèDepartment of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.
Gianluca LopezPathology Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy.ORCID 0000-0002-9262-1212
Fulvia Milena CribiùPathology Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Elena TrombettaClinical Chemistry and Microbiology Laboratory Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Marinos KallikourdisDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.ORCID 0000-0001-9318-3368
Marco CremonesiLaboratory of Adaptive Immunity, IRCCS Humanitas Research Hospital, Milan, Italy.ORCID 0000-0002-8817-2186
Francesco ConfortiGastroenterology and Endoscopy Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Fiorenzo BottiGastroenterology and Endoscopy Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Laura PorrettiClinical Chemistry and Microbiology Laboratory Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Maria RescignoDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Maurizio VecchiGastroenterology and Endoscopy Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy.ORCID 0000-0003-1558-8604
Massimo C FantiniDepartment of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.
Flavio CaprioliGastroenterology and Endoscopy Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Federica FacciottiDepartment of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0002-2541-9428
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITEuropean Institute of Oncology · ITUniversity of Milan · ITHumanitas University · ITIRCCS Humanitas Research Hospital · ITUniversity of Cagliari · IT

Funding

Associazione Italiana per la Ricerca sul Cancro 14378Italy's Ministry of Health GR-2016-0236174
6 · The paper itself

Abstract

BACKGROUND AND

aimsInvariant natural killer T [iNKT] cells perform pleiotropic functions in different tissues by secreting a vast array of pro-inflammatory and cytotoxic molecules. However, the presence and function of human intestinal iNKT cells capable of secreting immunomodulatory molecules such as IL-10 has never been reported so far. Here we describe for the first time the presence of IL10-producing iNKT cells [NKT10 cells] in the intestinal lamina propria of healthy individuals and of Crohn's disease [CD] patients.

methodsFrequency and phenotype of NKT10 cells were analysed ex vivo from intestinal specimens of Crohn's disease [n = 17] and controls [n = 7]. Stable CD-derived intestinal NKT10 cell lines were used to perform in vitro suppression assays and co-cultures with patient-derived mucosa-associated microbiota. Experimental colitis models were performed by adoptive cell transfer of splenic naïve CD4+ T cells in the presence or absence of IL10-sufficient or -deficient iNKT cells. In vivo induction of NKT10 cells was performed by administration of short chain fatty acids [SCFA] by oral gavage.

resultsPatient-derived intestinal NKT10 cells demonstrated suppressive capabilities towards pathogenic CD4+ T cells. The presence of increased proportions of mucosal NKT10 cells associated with better clinical outcomes in CD patients. Moreover, an intestinal microbial community enriched in SCFA-producing bacteria sustained the production of IL10 by iNKT cells. Finally, IL10-deficient iNKT cells failed to control the pathogenic activity of adoptively transferred CD4+ T cells in an experimental colitis model.

conclusionsThese results describe an unprecedentd IL10-mediated immunoregulatory role of intestinal iNKT cells in controlling the pathogenic functions of mucosal T helper subsets and in maintaining the intestinal immune homeostasis.

Indexed as

ColitisCrohn DiseaseNatural Killer T-CellsCD4-Positive T-LymphocytesHumansInterleukin-10Intestinal MucosaIL10 protein, humanInterleukin-10Crohn’s diseaseIL10iNKT cellsmicrobiotaSCFA

Identifiers

PMID35358301
PMCPMC9455792
OpenAlexW4220860675

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.